Argenica Therapeutics (ASX:AGN) functional gains strengthen case for next phase of stroke drug
Argenica Therapeutics (ASX:AGN) has released promising data from its Phase 2 clinical trial of ARG-007, a neuroprotective peptide designed to…
Argenica Therapeutics (ASX:AGN) has released promising data from its Phase 2 clinical trial of ARG-007, a neuroprotective peptide designed to…
Chariot Corporation (ASX:CC9) has confirmed the presence of extensive lithium-bearing pegmatite systems at its Fonlo and Iganna projects in southwest Nigeria, paving the way for both near-term production and long-term resource development.
Locksley Resources (ASX:LKY | OTCQX:LKYRF | FSE:X5L) has strengthened its U.S. strategic credentials with the appointment of retired U.S. Air Force Major General Peter J. Lambert to its Advisory Board, reinforcing its mine-to-market critical minerals strategy.
Elixir Energy (ASX:EXR) has confirmed 23 metres of net gas pay across multiple Permian formations at its Diona-1 exploration well in Queensland’s Surat-Bowen Basin, signalling potential for a new east coast gas source.
White Cliff Minerals (ASX:WCN) has identified multiple untested copper targets along a 10km structural corridor at its Rae Copper Project in Nunavut, revealing regional scale potential adjacent to the Danvers deposit.
Chief Executive Officer Lyle Thorne says Diablo Resources is advancing its Utah projects at a time when copper, silver and antimony are increasingly recognised as critical to America’s supply chain and national security.
Locksley Resources (ASX:LKY) has expanded the Desert Antimony Mine corridor at its Mojave Project fourfold to 1.2 kilometres, reinforcing its role in U.S. critical mineral supply strategy.